Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC)

This publication has 31 references indexed in Scilit:

• Standard uptake value and metabolic tumor volume of 18F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer
  European Journal of Nuclear Medicine and Molecular Imaging, 2011
• PET in radiotherapy planning: Particularly exquisite test or pending and experimental tool?
  Radiotherapy and Oncology, 2010
• PET scans in radiotherapy planning of lung cancer
  Radiotherapy and Oncology, 2010
• Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy 18Fluorodeoxyglucose-PET-CT scan
  Radiotherapy and Oncology, 2009
• FDG-PET, PET/CT and conventional nuclear medicine procedures in the evaluation of lung cancer
  Nuklearmedizin-Nuclear Medicine, 2009
• Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC)
  Lung Cancer, 2008
• A Pilot Study of [¹⁸F]Fluorodeoxyglucose Positron Emission Tomography Scans During and After Radiation-Based Therapy in Patients With Non–Small-Cell Lung Cancer
  Journal of Clinical Oncology, 2007
• Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy. A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients
  Radiotherapy and Oncology, 2007
• Prognostic Relevance of Response Evaluation Using [¹⁸F]-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Patients With Locally Advanced Non–Small-Cell Lung Cancer
  Journal of Clinical Oncology, 2005
• Use of PET to monitor the response of lung cancer to radiation treatment
  European Journal of Nuclear Medicine and Molecular Imaging, 2000